Iovance Biotherapeutics
IOVA
IOVA
219 hedge funds and large institutions have $3.73B invested in Iovance Biotherapeutics in 2020 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 74 increasing their positions, 69 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
8% more capital invested
Capital invested by funds: $3.44B → $3.73B (+$291M)
7% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 69
0.08% more ownership
Funds ownership: 98.38% → 98.46% (+0.08%)
Holders
219
Holding in Top 10
11
Calls
$112M
Puts
$20.3M
Top Buyers
| 1 | +$67.5M | |
| 2 | +$46.3M | |
| 3 | +$19.8M | |
| 4 |
RCAMU
Rothschild & Co Asset Management US
Stamford,
Connecticut
|
+$19.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$17.9M |
Top Sellers
| 1 | -$78.7M | |
| 2 | -$42.4M | |
| 3 | -$41.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$18.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$15M |